OTC Alternatives to Phentermine – Latest Craze

Phen375 is regarded as one of the best fat burners that are available in the market today. This diet pill has been preferred by million of people to meet their weight loss goals. The reason why people buy phen375 is that it provides an extensive fat loss reduction for anyone who wants to lose weight. This OTC diet pill is a combination of the different aspects of weight loss which includes enhances metabolism, eliminates excess glucose, burns fat quickly and suppresses appetite. These aspects make this die pill a very powerful weapon that combats weight loss. It can help a person to lose about 4 lbs per week.

The other reasons why people buy Phen375 are that this diet pill has been approved by the FDA and it has also passed many clinical tests before being launched in the market. This makes this supplement very safe to use and it is without any side effect. The ingredients that are used in this diet pill work independently after being tested separately by the FDA. Due to these reasons, phen375 is considered as the best selling fat burner in the market today. This diet pill provides extensive weight loss solution for people who want to lose weight by the way of calorie and fat burning process.

Therefore, the weight of your body can be reduced quickly and safely. The ingredients of this diet pill are all natural and thus the chances of having any kind of harmful side effects are considerably reduced. The results of using this diet pill has given positive outcomes which proves the effectiveness of the product for a person who wants to lose weight with the best weight loss supplement. It is a safe fat burner that has also been proved safe to use and thus you can buy phen375 if you want to lose weight.

Sticky Post

New STD Treatment Guidelines

The new CDC sexually transmitted treatment guidelines have finally arrived and are available on line at www.cdc.gov/std . These guidelines are evidence based, and although they emphasize treatment, prevention strategies and diagnostic recommendations are also discussed. The guidelines present new information in several areas for both men and women, such as:

  1. Expanded diagnostic evaluation for cervicitis and trichomoniasis;
  2. New treatment recommendations for bacterial vaginosis and genital warts;
  3. Clinical efficacy of azithromycin for chlamydial infection in pregnancy;
  4. Role of Mycoplasma genitalium and trichomoniasis in urethritis/cervicitis and treatment-related implications;
  5. Lymphogranuloma venereum proctocolitis among men who have sex with men (MSM);
  6. The criteria for spinal fluid examination to evaluate for neurosyphilis;
  7. The emergence of azithromycin-resistant Treponema pallidum;
  8. The increasing prevalence of antimicrobial-resistant Neisseria gonorrhoeae;
  9. The sexual transmission of hepatitis C;
  10. Diagnostic evaluation after sexual assault; and,
  11. STD prevention approaches.

This web update will focus on what’s new regarding the diagnosis and treatment of non-gonococcal urethritis in men. However, several webcasts reviewing the Guidelines are available through the CDC’s STD website as well as the National Network of Prevention Training Centers’ website (nnptc.org). In our next web update we will discuss treatment approaches for Neisseria gonorrhoeae infections.


The four principal outcomes of STD therapy for each individual disease are treatment of infection based on microbiologic eradication, alleviation of signs and symptoms, prevention of sequelae, and prevention of transmission. Often in the clinical setting, the patient presents for alleviation of signs and symptoms and the clinician’s job is to determine what the infection may be, what tests to order, what treatment to give, and what prevention and risk-reduction messages to impart to the specific client. This process begins with a sexual history which should be taken in a nonjudgmental and empathetic manner which is appropriate to the patient’s culture, language, sex, sexual orientation, age and developmental level. 2010 STD Treatment Guidelines, nicely outlines the five P’s of a good sexual history: Partners, Prevention of pregnancy, Protection from STDs, Practices, and Past history of STDs. Although we usually consider pregnancy prevention questions mainly for women, men should be queried regarding prevention of pregnancy also. Although this may not be pertinent for men who have sex exclusively with other men, assumptions should not be made without asking about partners: “Do you have sex with men, women, or both?” Getting the “Five P’s” information will also inform what interactive counseling approach the clinician will choose that can be directed at the patient’s personal risk, the situations in which risk occurs, and the use of personalized goal-setting strategies that may be effective for his STD/HIV prevention (2,3).


  1. www.cvdc.gov/std/treatment/2010
  2. Lin JS, Whitlock E, OConnor E, et al. Behavioral counseling to prevent sexually transmitted infections: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 149:497–9.
  3. U.S. Preventive Services Task Force. Behavioral counseling to prevent sexually transmitted infections: recommendation statement. Ann Intern Med 2008;149:491–6.